Certified by Founder Lodge
BioImpact Capital, an Affiliate of MPM Capital
United States - Boston, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $53,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
BioImpact Capital creates and invests in companies solving the world’s greatest unmet medical needs with its affiliate, MPM. We invest across the lifecycle of biotechnology companies, providi
| Company | Date | Round | Raised |
|---|---|---|---|
 Antiva Biosciences, Inc. |
April, 27 ,2023 | Series E | $53,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
